1. Home
  2. GPCR vs DGII Comparison

GPCR vs DGII Comparison

Compare GPCR & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • DGII
  • Stock Information
  • Founded
  • GPCR 2016
  • DGII 1985
  • Country
  • GPCR United States
  • DGII United States
  • Employees
  • GPCR N/A
  • DGII N/A
  • Industry
  • GPCR
  • DGII Computer peripheral equipment
  • Sector
  • GPCR
  • DGII Technology
  • Exchange
  • GPCR Nasdaq
  • DGII Nasdaq
  • Market Cap
  • GPCR 1.1B
  • DGII 980.4M
  • IPO Year
  • GPCR 2023
  • DGII N/A
  • Fundamental
  • Price
  • GPCR $23.20
  • DGII $27.18
  • Analyst Decision
  • GPCR Strong Buy
  • DGII Buy
  • Analyst Count
  • GPCR 8
  • DGII 5
  • Target Price
  • GPCR $80.71
  • DGII $33.60
  • AVG Volume (30 Days)
  • GPCR 1.3M
  • DGII 213.2K
  • Earning Date
  • GPCR 05-08-2025
  • DGII 05-07-2025
  • Dividend Yield
  • GPCR N/A
  • DGII N/A
  • EPS Growth
  • GPCR N/A
  • DGII 119.70
  • EPS
  • GPCR N/A
  • DGII 0.95
  • Revenue
  • GPCR N/A
  • DGII $421,823,000.00
  • Revenue This Year
  • GPCR N/A
  • DGII $2.08
  • Revenue Next Year
  • GPCR N/A
  • DGII $4.37
  • P/E Ratio
  • GPCR N/A
  • DGII $27.79
  • Revenue Growth
  • GPCR N/A
  • DGII N/A
  • 52 Week Low
  • GPCR $13.22
  • DGII $20.17
  • 52 Week High
  • GPCR $62.74
  • DGII $37.07
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 64.61
  • DGII 50.97
  • Support Level
  • GPCR $17.94
  • DGII $23.93
  • Resistance Level
  • GPCR $24.17
  • DGII $27.89
  • Average True Range (ATR)
  • GPCR 1.81
  • DGII 1.62
  • MACD
  • GPCR 1.08
  • DGII 0.32
  • Stochastic Oscillator
  • GPCR 89.94
  • DGII 89.45

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

Share on Social Networks: